The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Nationwide Children's Hospital
Study ID
NCT07718204
Status
Recruiting

Conditions

  • Hematopoietic Cell Transplant

Eligibility Criteria

Sex
ALL
Age
0 Years - 12 Years
Healthy Volunteers
Not accepted

Interventions

  • MedMemos — BEHAVIORAL
    MedMemos is a 4-session tailored adherence promotion intervention that will provide caregivers with a combination of tailored and standardized medication and adherence education videos and a "Medication Management Kit" that provides tailored strategies to target identified barriers to successful medication management.

Study Details

The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are: * Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better? Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.

Key Dates

First listed
Jul 21, 2026
Start date
May 1, 2026
Status verified
Jul 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: MedMemos
    This arm will provide participants with the MedMemos Intervention

Primary Outcome Measure

Intervention Acceptability [ Time Frame: At the end of session 4 (An average of 14 days following the patient's hospital discharge, up to 28 days following discharge) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Nationwide Children's HospitalColumbusOhio43205
Ahna LH Pai, PhD
(614) 938-1601
Sarah N Drake, MS
(614) 259-7462
Ahna LH Pai, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Columbus, OH

Related Studies